Susquehanna International Group, LLP Soleno Therapeutics Inc Call Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$0.14 - $0.23 $140 - $230	-1,000 Reduced 8.26%	11,100 $2,000
Q1 2022 May 16, 2022	SELL	$0.22 - $0.47 $4,422 - $9,447	-20,100 Reduced 62.42%	12,100 $3,000
Q4 2021 Feb 14, 2022	SELL	$0.41 - $0.91 $31,487 - $69,888	-76,800 Reduced 70.46%	32,200 $13,000
Q3 2021 Nov 15, 2021	SELL	$0.8 - $1.12 $3,600 - $5,040	-4,500 Reduced 3.96%	109,000 $101,000
Q2 2021 Aug 11, 2021	BUY	$0.97 - $1.32 $83,711 - $113,916	86,300 Added 317.28%	113,500 $129,000
Q1 2021 May 17, 2021	BUY	$1.24 - $3.3 $15,748 - $41,910	12,700 Added 87.59%	27,200 $34,000
Q4 2020 Feb 16, 2021	SELL	$1.61 - $2.23 $122,360 - $169,480	-76,000 Reduced 83.98%	14,500 $28,000
Q3 2020 Nov 16, 2020	SELL	$1.71 - $2.51 $131,157 - $192,516	-76,700 Reduced 45.87%	90,500 $227,000
Q2 2020 Aug 14, 2020	BUY	$1.77 - $4.23 $295,944 - $707,256	167,200 New	167,200 $371,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $413M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.